Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen season

Immunotherapy

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

JAMA.

Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR

doi: 10.1001/jama.2016.21040.

Immunotherapy

Nasal Allergen Neutralising IgG₄ Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

J Allergy Clin Immunol.

Shamji MH, Kappen J, Abubakar-Waziri H, Zhang J, Steveling E, Watchman S, Kouser L, Eifan A, Switzer A, Varrichi G, Marone G, Couto-Francisco NC, Calderon M, Durham SR

doi: 10.1016/j.jaci.2018.09.039.

Allergic DiseasesImmunotherapy

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Allergy.

Schmid JM, Würtzen PA, Siddhuraj P, Jogdand P, Petersen CG, Dahl R, Erjefält JS, Hoffmann HJ

doi: 10.1111/all.14264.

Allergic DiseasesImmunotherapy

Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma

J Allergy Clin Immunol.

Pfaar O, Bachert C, Kuna P, Panzner P, Džupinová M, Klimek L, van Nimwegen MJ, Boot JD, Yu D, Opstelten DJE, de Kam PJ

doi: 10.1016/j.jaci.2018.11.018.

Immunotherapy

Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinitis

Allergy.

Pfaar O, Lang S, Pieper-Fürst U, Astvatsatourov A, Gerich F, Klimek L, Kramer MF, Reydelet Y3 Shah-Hosseini K, Mösges R

doi: 10.1111/all.13240.

Allergic Diseases

Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - an EAACI Task Force Report

Allergy.

Pfaar O, Karatzas K, Bastl K, Berger U, Buters J, Darsow U, Demoly P, Durham SR, Galán C, Gehrig R, Gerth van Wijk R, Jacobsen L, Katsifarakis N, Klimek L, Saarto A, Sofiev M, Thibaudon M, Werchan B, Bergmann KC

doi: 10.1111/all.14111.

Allergic Diseases

Polyvalent mechanical bacterial lysate administration improves the clinical course of grass pollen-induced allergic rhinitis in children: a randomised controlled trial

J Allergy Clin Immunol Pract.

Janeczek K, Emeryk A, Rachel M, Duma D, Zimmer L, Poleszak E

doi: 10.1016/j.jaip.

Allergic DiseasesImmunotherapy

Intralymphatic Immunotherapy improves grass pollen allergic rhinoconjunctivitis. A three-year randomized placebo-controlled trial

J Allergy Clin Immunol.

Skaarup SH, Schmid JM, Skjold T, Graumann O, Hoffmann HJ

doi: 10.1016/j.jaci.2020.07.002.

Allergic DiseasesImmunotherapy

Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

Pediatr Allergy Immunol.

Gur Cetinkaya P, Kahveci M, Esenboga S, Karaatmaca B, Soyer O, Sekerel BE, Tuncer A, Sahiner UM

doi: 10.1111/pai.13261.

Related content

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.

Nasal Allergen Neutralising IgG4 Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy

Basophil Sensitivity Reflects the Long-term Clinical Outcome of Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

Sublingual allergen immunotherapy with a liquid birch pollen product in seasonal allergic rhinoconjunctivitis with/without asthma

Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinitis

Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - an EAACI Task Force Report

Polyvalent mechanical bacterial lysate administration improves the clinical course of grass pollen-induced allergic rhinitis in children: a randomised controlled trial

Intralymphatic Immunotherapy improves grass pollen allergic rhinoconjunctivitis. A three-year randomized placebo-controlled trial

Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

Nasal Allergen Neutralising IgG₄ Antibodies Block IgE-mediated Responses: Novel biomarker of Subcutaneous Grass Pollen Immunotherapy